3 recruiting, 2 completed, 1 not yet recruiting. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Recruiting 3, Completed 2, Not yet recruiting 1 |
Follow Polyradiculoneuropathy: new trials by email Literature Review of Polyradiculoneuropathy trials Research Report on Polyradiculoneuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases CD19/BCMA-targeted CAR-T cells, Lymphodepleting Conditioning - Relapsing or Refractory Multiple Sclerosis (MS), Myasthenia Gravis (MG) | Early Phase 1 | Recruiting | Tongji Hospital | 36 | 2025-12-12 | 2026-05-12 |
| Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases UCAR T-cell - Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis | Early Phase 1 | Recruiting | Tianjin Huanhu Hospital | 12 | 2025-06-17 | 2025-12-15 |
| Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. Universal BCMA CAR-T, Universal CD19 CAR-T, Universal BCMA CAR-T; Universal CD19 CAR-T - Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Generalized | Early Phase 1 | Not yet recruiting | Xuanwu Hospital, Beijing | 25 | 2025-02-28 | 2025-01-01 |
| Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology Virtual Assistant - Stroke, Guillain-Barre Syndrome | Early Phase 1 | Completed | Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia | 10 | 2023-10-01 | 2024-03-28 |
| Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Blood sampling - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Early Phase 1 | Completed | Centre Hospitalier Universitaire de Nīmes | 8 | 2021-03-12 | 2025-12-10 |
| Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System CT103A cells, Cyclophosphamide and fludarabine - Autoimmune Diseases, Autoimmune Diseases of the Nervous System | Early Phase 1 | Recruiting | Tongji Hospital | 36 | 2020-09-22 | 2024-10-30 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (5) · Multiple Sclerosis (4) · Myasthenia Gravis (4) · Autoimmune Diseases of the Nervous System (3) · Neuromyelitis Optica (3) · Autoimmune Diseases (1) · Benign Paroxysmal Positional Vertigo (1) · Delirium (1) · Facial Paralysis (1) · Guillain-Barre Syndrome (1) · Meningitis (1) · Migraine Disorders (1) · Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1) · Myositis (1) · POEMS Syndrome (1)
Chronic Disease (6) · Demyelinating Diseases (6) · Disease Attributes (6) · Immune System Diseases (6) · Nervous System Diseases (6) · Neuromuscular Diseases (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Peripheral Nervous System Diseases (6) · Polyneuropathies (6) · Autoimmune Diseases (5) · Cranial Nerve Diseases (4) · Demyelinating Autoimmune Diseases, CNS (4) · Neoplasms (4)
Blood Specimen Collection (1) · Cyclophosphamide (1) · fludarabine (1)
Tongji Hospital (2) · Centre Hospitalier Universitaire de Nīmes (1) · Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (1) · Tianjin Huanhu Hospital (1) · Xuanwu Hospital, Beijing (1)
China (4) · Argentina (1) · France (1)
Chuan Qin, Prof. (1) · Daishi Tian, Prof. (1) · Mauricio F Farez, MD MPH (1) · Wei Wang, MD (1)